Testing in-line duct air treatment systems

In-line duct air treatment system testing measures how HVAC or process-air devices perform when air passes through a defined duct section. ASHRAE 241, ASHRAE 185.2, ISO 10121, ISO 6145, and ISO 17025 quality controls frame the study design for microbial reduction, gas challenge stability, VOC removal, and airflow interpretation. Testing supports development, claims, and customer documentation when:

  1. Duct-mounted UVGI, filtration, ionization, or hybrid systems need ASHRAE 241 aligned single-pass bioaerosol reduction data with upstream/downstream sampling.
  2. Sorbent, catalyst, or reactive media modules require ISO 10121 aligned VOC removal, breakthrough, or capacity data at installed duct airflow.
  3. Gas-phase evaluations need ISO 6145 aligned challenge delivery so inlet concentration, RH, temperature, and flow stability are documented before performance is interpreted.
  4. Unusual duct geometry, bypass risk, or sampling-location uncertainty needs ASHRAE airflow context and CFD-supported review before final bench conditions are locked.
  5. Customer or regulatory files require ISO 17025 records tying device mode, flow, organism or gas challenge, controls, calculations, and deviations together.

Use this testing when duct velocity, residence time, mixing, media condition, active settings, or sampling layout could change the apparent device performance. The protocol fixes the duct setup, challenge input, controls, endpoint, and reporting basis before testing begins.

Core tests for inline duct air treatment systems

Inline duct programs usually combine single-pass microbial reduction, traceable gas challenge delivery, VOC removal, and flow modeling. Select the set by claim, technology, and installation geometry.

Test method options

MethodStrengthsTradeoffAligned with
Inline bioaerosol reduction study
  • Measures upstream/downstream microbial aerosol reduction for duct devices under ASHRAE 241 aligned single-pass conditions.
  • Device-off baselines separate treatment effect from duct loss, sampler recovery, and background decay.
Organism, surrogate, and biosafety choices must match the claim before endpoint sensitivity can be judged.
ASHRAE 241ISO 17025
Gas challenge delivery qualification
  • Verifies inlet gas concentration, flow, RH, temperature, and stability before device performance is interpreted.
  • ISO 6145 aligned delivery records document source concentration, dilution ratio, and interface losses.
This qualifies the challenge system; it does not prove long-term field performance by itself.
ISO 6145ISO 17025
Gas and VOC removal or destruction study
  • Measures inlet/outlet concentration, single-pass removal, destruction efficiency, breakthrough, and capacity for sorbent or catalytic modules.
  • ISO 10121 and ASHRAE 145.2 aligned runs compare media, residence time, and humidity effects.
Target compounds and endpoint criteria must be selected before setup because chemistry drives sampling and run length.
ISO 10121 / ASHRAE 145.2ISO 17025
CFD-assisted duct configuration review
  • Models airflow, mixing, bypass, residence time, and sampling-location risk before physical test conditions are finalized.
  • ASHRAE and AIAA guidance frames model validation, mesh sensitivity, and boundary-condition documentation.
CFD supports setup and interpretation; measured inlet/outlet data remain necessary for final performance claims.
ASHRAE / AIAA CFD validationISO 17025

Setup configurations

Every inline duct study is configured around the device geometry, operating mode, airflow target, challenge input, and endpoint. The same device may need different duct sections for microbial reduction, gas-phase breakthrough, or CFD validation. Study planning locks fixture dimensions, sampling locations, flow control, environmental conditions, device state, controls, and replicate structure before collection begins.

Device interfaces

Duct inserts, sealed adapters, media beds, UVGI modules, bypass checks, pressure taps, and upstream/downstream sampling ports matched to the device geometry.

Flow & actuation profiles

Volumetric flow, duct velocity, fan speed, residence time, lamp or power setting, warmup, duty cycle, and operating mode documented per condition.

Environmental controls

Temperature, RH, pressure condition, media conditioning, lamp state, gas stability, and background aerosol levels logged when they affect removal or reduction.

Sample numbers

Replicate device-on runs, device-off baselines, blanks, challenge-stability checks, and condition blocks sized to variability and the decision threshold.

Calibration & verification

Flow meters, samplers, gas analyzers, environmental probes, analytical assays, and CFD validation inputs checked against defined acceptance criteria.

Quality frame for inline duct testing

Inline duct studies separate the accredited laboratory quality anchor from aligned building, gas, and filtration method frames. The anchors below define how controls, calibration, and reporting are documented.

  • ISO 17025AccreditedLaboratory competence, calibration traceability, method records, and data review.
  • ASHRAE 241AlignedInfectious aerosol control and equivalent clean airflow context.
  • ISO 6145AlignedDynamic gas mixture generation and delivery uncertainty.
  • ISO 10121 / ASHRAE 145.2AlignedGas-phase filter, sorbent, and duct device performance.

Key data outputs & reporting

Inline duct reports connect device operation to paired upstream and downstream measurements across each condition. Results can include single-pass bioaerosol reduction, gas challenge stability, removal efficiency, breakthrough behavior, capacity estimates, airflow condition records, CFD assumptions, QA/QC controls, and interpretation limits. Extended programs comparing device modes, media states, geometries, or target gases receive additional comparison artifacts.

Primary outputs

  • Upstream and downstream microbial, particle, gas, or VOC concentration by condition, time interval, and device mode.
  • Single-pass reduction, log reduction where appropriate, removal efficiency, destruction efficiency, breakthrough point, or usable capacity.
  • Duct airflow, RH, temperature, pressure, residence time, device setting, and challenge-stability records tied to each run.
  • CFD velocity, mixing, bypass, residence-time, or sampling-location outputs with assumptions and validation evidence stated.

Deliverables

#FormatContents
01PDF reportMethods, duct setup, controls, calculations, figures, QA/QC, deviations, and interpretation limits.
02CSV / XLSX datasetsConcentration, flow, environmental, reduction, removal, and replicate data by condition.
03FiguresInlet/outlet overlays, breakthrough curves, mode comparisons, and CFD visuals when included.
Extended deliverables · multi-arm comparability · stability · predicate studies
  • Configuration comparison packSide-by-side results across device modes, flow settings, media states, or duct geometries.
  • Modeling appendixCFD assumptions, boundary conditions, sensitivity results, and validation comparisons against measured data.

QA / QC & data integrity

Inline duct studies use controls that separate true device performance from duct loss, challenge instability, sampler artifacts, analytical drift, and environmental variation. Records are maintained under the ISO 17025 quality system from sample receipt through final review, with traceability for devices, challenge sources, instruments, raw data, calculations, and deviations.

Device-off baselines, blanks, negative controls, and background runs define line loss and pre-challenge conditions.

Sampler flow, duct flow, gas delivery, RH, temperature, and analytical instruments are checked or calibrated before use.

Challenge stability, duct mixing, sampling losses, carryover, and inlet/outlet timing are documented per condition.

Biological samples and analytical extracts are tracked by chain of custody, recovery checks, and endpoint-specific controls.

Replicate rules, acceptance criteria, calculation methods, deviations, and exclusions are retained in the study record.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Quick answers to questions HVAC engineers, air-treatment developers, and product teams ask when scoping inline duct studies: which endpoint to choose, how the duct setup is defined, how many devices are needed, what drives timeline, and whether the work certifies the product. Most programs need at least one fixture, challenge, or operating-mode decision resolved during planning.

Q.How is the right inline method selected?
A.Start with the claim or decision. Microbial reduction points to inline bioaerosol testing, gas removal points to inlet/outlet chemistry, and geometry uncertainty points to CFD-supported setup review.
Q.How many devices or samples are needed?
A.Device count depends on model variability, operating modes, media or lamp condition, challenge type, and whether the work is screening or claim support. We define replicates during protocol development.
Q.What drives timeline and scope?
A.Main drivers are duct fixture complexity, target airflow, challenge stability, organism or gas selection, analytical method, controls, and whether CFD or by-product screening is included.
Q.What data will we receive?
A.Deliverables can include raw and processed concentration data, reduction or removal calculations, challenge verification, airflow records, CFD outputs, QA/QC records, and a technical report.
Q.Does this testing certify the duct system?
A.No. ARE Labs provides defined aerosol, bioaerosol, gas, VOC, airflow, and documentation evidence. Electrical safety, installation-code compliance, UL validation, and CARB certification require other specialists.